BeStock  

HCA Healthcare HCA

US equityMarket cap rank #198Medical Care Facilities
$475.57 +$15.24 (+3.31%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $476.00 +0.09%
Open$467.00
Prev close$460.33
Day range$463.50 – $479.77
Volume1.58M
Market cap$99.34B
P/E (TTM)15.8
Dividend yield0.64%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership94.5%+0.76 pts vs. prior quarter
Institutions holding1,665-7 vs. prior quarter
Insider trades (recent)24 buys / 24 sellsBalanced
Short interest2.30% of floatDays to cover 3.3 · as of 30 Oct 2026
Short-sale volume share18.2%5-day average of daily volume

Short-sale volume as % of daily volume

11%17%22%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$183.88M (4 inflow days, 16 outflow days).

Net flow by order size, last 20 sessions

−$7.7MSuper−$176.2MBig−$62.7MMid−$2.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 48.0% of shares outstanding.

Largest holders

  • Frisco Holding II17.50%
  • Hercules Holding Ii, LLC15.45%
  • BlackRock5.95%
  • Vanguard Capital Management, LLC4.91%
  • Sanders Capital, LLC4.21%
  • State Street Global Advisors3.35%
  • Capital Research2.24%
  • Wellington Management Group2.06%

By investor type

  • Mutual Fund51.24%
  • Private Company34.36%
  • Hedge Fund2.56%
  • Public Company2.38%
  • Government Pension Fund1.85%
  • Individual/Insider1.48%
  • Sovereign Wealth Fund1.06%
  • Insurance Company0.27%

Reported short interest has fallen from 2.83% to 2.30% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Capital Research Mutual Fund 2026/Q3 +794,171 2.2%
Deka Investment GmbH Mutual Fund 2026/Q3 +326,441 0.2%
Jane Street Group, LLC Private Company 2026/Q3 +243,474 0.1%
Amundi Asset Management Mutual Fund 2026/Q3 +218,457 0.3%
Franklin Resources Mutual Fund 2026/Q3 +190,129 0.6%
Life Cycle Investment Partners Limited Mutual Fund 2026/Q3 +158,519 0.5%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +122,894 0.3%
Employees Retirement System of Texas Government Pension Fund 2026/Q3 +119,000 0.1%
Crake Asset Management LLP Hedge Fund 2026/Q3 +1,151,792 0.6%
Wellington Management Group Mutual Fund 2026/Q3 +799,761 2.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +756,768 0.6%
Metropolis Capital Limited Mutual Fund 2026/Q3 +602,264 0.4%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +515,905 0.9%
Consulta Ltd. Hedge Fund 2026/Q3 +400,000 0.2%
Darsana Capital Partners LP Hedge Fund 2026/Q3 +350,000 0.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 Erica Rossitto Senior VP & Chief Nurse Executive Derivative Exercise and Sale -10,101 $505.81 13,426
5 Nov 2026 Erica Rossitto Senior VP & Chief Nurse Executive Derivative Exercise and Retained +3,019 $81.96 13,426
5 Nov 2026 Jon Foster Chief Operating Officer Open Market Disposition -31,713 $514.07 178,374
3 Nov 2026 Jon Foster Chief Operating Officer Other Disposition -571 $503.53 178,374
3 Nov 2026 Jon Foster Chief Operating Officer Derivative Exercise and Sale -35,880 $510.70 178,374
3 Nov 2026 Hercules Holding Ii, LLC Other Acquisition +555,500 $503.53 32,282,889
3 Nov 2026 Hercules Holding Ii, LLC Other Disposition -555,500 $503.53 32,282,889
3 Nov 2026 Michael Schlosser Executive Vice President & Chief Clinical Officer Open Market Disposition -1,200 $494.65 8,394
1 Nov 2026 Michael Marks Chief Financial Officer Derivative Exercise and Sale -4,371 $473.19 74,332
29 Oct 2026 Michael Marks Chief Financial Officer Derivative Exercise and Retained +214 $81.96 74,332
28 Oct 2026 Michael Schlosser Executive Vice President & Chief Clinical Officer Derivative Exercise and Sale -2,455 $478.08 9,594
28 Oct 2026 Michael Schlosser Executive Vice President & Chief Clinical Officer Other Derivative Acquisition +2,797 $478.08 2,797
28 Oct 2026 Michael Schlosser Executive Vice President & Chief Clinical Officer Derivative Exercise and Retained +2,473 $81.96 9,594
31 Aug 2026 Michael Schlosser Executive Vice President & Chief Clinical Officer Initial Statement of Beneficial +0 – 40,712
25 Aug 2026 Michael McAlevey Executive VP and Chief Legal & Administrative Officer Other Disposition -7,769 $429.00 10,990
6 May 2026 Michael Marks Chief Financial Officer Other Acquisition +3,336 – 73,076
6 May 2026 Michael Marks Chief Financial Officer Other Disposition -3,336 – 73,076
27 Apr 2026 John Chidsey Independent Director Other Acquisition +809 – 809
27 Apr 2026 Michael Michelson Independent Director Other Acquisition +925 – 12,576
27 Apr 2026 Nancy-Ann DeParle Independent Director Other Acquisition +509 – 509

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,800,941 2.3% 3.3
15 Oct 2026 4,906,014 2.3% 4.6
30 Sep 2026 4,884,718 2.3% 3.1
15 Sep 2026 6,479,985 3.0% 4.5
31 Aug 2026 6,135,558 2.8% 4.9
14 Aug 2026 6,127,018 2.8% 5.6

Discussion

No comments yet — be the first to weigh in on HCA.

Sign in to join the discussion.

Scroll to Top